DE60221227D1 - Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen - Google Patents

Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen

Info

Publication number
DE60221227D1
DE60221227D1 DE60221227T DE60221227T DE60221227D1 DE 60221227 D1 DE60221227 D1 DE 60221227D1 DE 60221227 T DE60221227 T DE 60221227T DE 60221227 T DE60221227 T DE 60221227T DE 60221227 D1 DE60221227 D1 DE 60221227D1
Authority
DE
Germany
Prior art keywords
xanthan gum
reepithelializing
pharmaceutical preparations
epithelializing
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221227T
Other languages
English (en)
Other versions
DE60221227T2 (de
Inventor
Maria Grazia Mazzone
Grazia Paladino
Clara Marino
Ornella Peri
Vincenzo Enea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIFI SpA
Original Assignee
SIFI SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIFI SpA filed Critical SIFI SpA
Publication of DE60221227D1 publication Critical patent/DE60221227D1/de
Application granted granted Critical
Publication of DE60221227T2 publication Critical patent/DE60221227T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60221227T 2002-04-30 2002-04-30 Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen Expired - Lifetime DE60221227T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02425274A EP1358883B8 (de) 2002-04-30 2002-04-30 Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
DE60221227D1 true DE60221227D1 (de) 2007-08-30
DE60221227T2 DE60221227T2 (de) 2008-01-31

Family

ID=28799773

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60221227T Expired - Lifetime DE60221227T2 (de) 2002-04-30 2002-04-30 Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen
DE07108593T Pending DE07108593T1 (de) 2002-04-30 2002-04-30 Reepithelialisierende pharmazeutische Zusammensetzungen, die Xanthangummi enthalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE07108593T Pending DE07108593T1 (de) 2002-04-30 2002-04-30 Reepithelialisierende pharmazeutische Zusammensetzungen, die Xanthangummi enthalten

Country Status (15)

Country Link
US (5) US8912164B2 (de)
EP (2) EP1358883B8 (de)
JP (2) JP4837912B2 (de)
CN (1) CN100502884C (de)
AT (2) ATE367165T1 (de)
AU (1) AU2003230224B2 (de)
BR (1) BR0304655A (de)
CA (2) CA2484020C (de)
DE (2) DE60221227T2 (de)
DK (1) DK1358883T3 (de)
ES (2) ES2304913T3 (de)
MX (1) MXPA04010668A (de)
PT (1) PT1358883E (de)
RU (1) RU2297230C2 (de)
WO (1) WO2003092706A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304913T3 (es) * 2002-04-30 2012-03-01 Sifi S.P.A. Composiciones farmacéuticas reepitelializantes que contienen goma de xantano.
JP2005530768A (ja) 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
JP4948176B2 (ja) * 2004-09-28 2012-06-06 千寿製薬株式会社 キサンタンガムおよびアミノ酸を含有する眼科用組成物
ITRM20050443A1 (it) * 2005-08-12 2007-02-13 Opocrin Spa Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea.
JP5244584B2 (ja) * 2006-03-23 2013-07-24 千寿製薬株式会社 キサンタンガムおよびブドウ糖を含有する眼科用組成物
US20110117189A1 (en) * 2008-07-08 2011-05-19 S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. Ophthalmic compositions for treating pathologies of the posterior segment of the eye
JP5620168B2 (ja) * 2010-06-30 2014-11-05 Ｄｓｐ五協フード＆ケミカル株式会社 キシログルカン−カチオン複合体及びそれを含有する安定化組成物
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
CN104144690B (zh) * 2011-11-24 2017-12-29 东洋精糖株式会社 角结膜保护剂或角结膜障碍抑制剂
WO2016185935A1 (ja) * 2015-05-18 2016-11-24 柿原秀己 抗菌物質及び液状抗菌剤並びに液状抗菌剤の製造方法
JP6955497B2 (ja) * 2015-12-29 2021-10-27 インターベット インターナショナル ベー． フェー． コクシジウム症ワクチン
CN106236704A (zh) * 2016-08-30 2016-12-21 上海昊海生物科技股份有限公司 一种兼具仿生和靶向功能的莫西沙星滴眼液及其制备方法
CN114245737A (zh) 2019-06-11 2022-03-25 司斐股份有限公司 微乳剂组合物
IT202000002296A1 (it) * 2020-02-06 2021-08-06 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia
MX2021003369A (es) * 2021-03-22 2022-09-23 Laboratorios Grin S A De C V Lágrima ocular triple.
IT202200000821A1 (it) * 2022-01-19 2023-07-19 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4826872A (en) 1986-12-03 1989-05-02 Takeda Chemical Industries, Ltd. Pharmaceutical composition for treatment of cataract
JPH0723317B2 (ja) * 1988-03-17 1995-03-15 生化学工業株式会社 角膜上皮層障害症治療剤
JPH0651638B2 (ja) * 1989-02-13 1994-07-06 新技術事業団 角膜上皮創傷治療用点眼剤
US5271943A (en) * 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
IT1243435B (it) * 1990-10-05 1994-06-10 Altergon Sa Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
US5804213A (en) * 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
US6277365B1 (en) * 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
WO2000042986A2 (de) * 1999-01-19 2000-07-27 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Künstliche tränenflüssigkeit in gelform
AU2000269264A1 (en) * 2000-08-23 2002-03-04 Eidgenossische Technische Hochschule Zurich (Eth) Treatment of trauma, and other indications
AU2002232437A1 (en) * 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
ES2304913T3 (es) * 2002-04-30 2012-03-01 Sifi S.P.A. Composiciones farmacéuticas reepitelializantes que contienen goma de xantano.

Also Published As

Publication number Publication date
EP1913948A1 (de) 2008-04-23
ES2290264T3 (es) 2008-02-16
US20050234011A1 (en) 2005-10-20
EP1358883B8 (de) 2007-10-03
EP1358883B1 (de) 2007-07-18
AU2003230224B2 (en) 2008-07-17
JP4837912B2 (ja) 2011-12-14
CA2484020C (en) 2011-10-25
DE07108593T1 (de) 2008-12-04
PT1358883E (pt) 2007-10-01
CA2749172C (en) 2013-04-09
EP1358883A1 (de) 2003-11-05
JP5203472B2 (ja) 2013-06-05
MXPA04010668A (es) 2005-06-20
WO2003092706A1 (en) 2003-11-13
CN100502884C (zh) 2009-06-24
CA2484020A1 (en) 2003-11-13
ATE528009T1 (de) 2011-10-15
JP2011102315A (ja) 2011-05-26
ES2304913T1 (es) 2008-11-01
AU2003230224A1 (en) 2003-11-17
CN1649602A (zh) 2005-08-03
BR0304655A (pt) 2004-07-20
JP2005529906A (ja) 2005-10-06
ATE367165T1 (de) 2007-08-15
US8912164B2 (en) 2014-12-16
ES2304913T3 (es) 2012-03-01
CA2749172A1 (en) 2003-11-13
DE60221227T2 (de) 2008-01-31
US20080139522A1 (en) 2008-06-12
US20160166601A1 (en) 2016-06-16
US20080146530A1 (en) 2008-06-19
US20080139502A1 (en) 2008-06-12
DK1358883T3 (da) 2007-11-12
RU2004131550A (ru) 2005-06-10
EP1913948B1 (de) 2011-10-12
RU2297230C2 (ru) 2007-04-20

Similar Documents

Publication Publication Date Title
DE60221227D1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen
HRP20060240T3 (en) Intranasal formulation of rotigotine
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
ATE464880T1 (de) Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
IS6344A (is) Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja
DK1157037T3 (da) GCSF-konjugater
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
ATE447397T1 (de) Darreichungsform mit erhöhter bioverfügbarkeit
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
CY1110664T1 (el) Ενδορινικες συνθεσετς
CO5231147A1 (es) Composicion congelante
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
EA200702496A1 (ru) Местная композиция, содержащая желатин
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
EP1411956B8 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
EA200701525A1 (ru) Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением
AR050937A1 (es) Composicion para administracion a traves de la mucosa y metodo para aumentar la absorcion a traves de la mucosa
SE0203817D0 (sv) New composition
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
AR029965A1 (es) Composiciones farmaceuticas con contenido de tobramicina y goma de xantano
HRPK20040924B3 (en) Preparation based on curcumae longae rhizomae roots
CY1109453T1 (el) Παραγωγα κινολινης και η χρηση τους στο γλαυκωμα και τη μυωπια

Legal Events

Date Code Title Description
8364 No opposition during term of opposition